Product Details
Clavulin
Amoxicillin + Clavulanic Acid50 mg + 12.5 mg/mL
Powder for Oral Suspension
DIN/PIN/NPN
01916874
Manufacturer
GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
Formulary Listing Date
1996-10-01
Unit Price
0.2554
Amount MOH Pays
0.1216
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.
ATC Code
J01CR02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 01916874 | Clavulin | 0.2554 | 0.1216 |
| 02542226 | M-Amoxi Clav | 0.1216 | 0.1216 |
| 02539438 | Jamp Amoxi Clav Suspension | 0.1216 | 0.1216 |